Machine learning models to predict end-stage kidney disease in chronic kidney disease stage 4
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Machine learning models to predict end-stage kidney disease in chronic kidney disease stage 4 ; volume:24 ; number:1 ; day:19 ; month:12 ; year:2023 ; pages:1-10 ; date:12.2023
BMC nephrology ; 24, Heft 1 (19.12.2023), 1-10, 12.2023
- Urheber
-
Takkavatakarn, Kullaya
Oh, Wonsuk
Cheng, Ella
Nadkarni, Girish N.
Chan, Lili
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12882-023-03424-7
- URN
-
urn:nbn:de:101:1-2024030321192762260123
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Takkavatakarn, Kullaya
- Oh, Wonsuk
- Cheng, Ella
- Nadkarni, Girish N.
- Chan, Lili
- SpringerLink (Online service)
Ähnliche Objekte (12)
Fabry Disease Presenting as End-Stage Kidney Disease
Health-related physical fitness in end-stage kidney disease
Multilayer network analysis in patients with end-stage kidney disease
Geriatric Assessment in Elderly Patients with End-Stage Kidney Disease
Blood Pressure Variability and Frailty in End-Stage Kidney Disease
Barriers to Implementing the Kidney Disease Outcomes Quality Initiative End-Stage Kidney Disease Life Plan Guideline
Validation of the kidney failure risk equation for end-stage kidney disease in Southeast Asia
Apolipoprotein A5 gene polymorphism (rs662799) and cardiovascular disease in end-stage kidney disease patients
Dysfunction of natural killer cells in end-stage kidney disease on hemodialysis
Epidemiology and aetiology of dialysis-treated end-stage kidney disease in Libya
LDLR gene polymorphism (rs688) affects susceptibility to cardiovascular disease in end-stage kidney disease patients
Urine 6-bromotryptophan: associations with genetic variants and incident end-stage kidney disease
Fabry Disease Presenting as End-Stage Kidney Disease
Health-related physical fitness in end-stage kidney disease
Multilayer network analysis in patients with end-stage kidney disease
Geriatric Assessment in Elderly Patients with End-Stage Kidney Disease
Blood Pressure Variability and Frailty in End-Stage Kidney Disease
Barriers to Implementing the Kidney Disease Outcomes Quality Initiative End-Stage Kidney Disease Life Plan Guideline
Validation of the kidney failure risk equation for end-stage kidney disease in Southeast Asia
Apolipoprotein A5 gene polymorphism (rs662799) and cardiovascular disease in end-stage kidney disease patients
Dysfunction of natural killer cells in end-stage kidney disease on hemodialysis
Epidemiology and aetiology of dialysis-treated end-stage kidney disease in Libya
LDLR gene polymorphism (rs688) affects susceptibility to cardiovascular disease in end-stage kidney disease patients
Urine 6-bromotryptophan: associations with genetic variants and incident end-stage kidney disease
Fabry Disease Presenting as End-Stage Kidney Disease
Health-related physical fitness in end-stage kidney disease
Multilayer network analysis in patients with end-stage kidney disease
Geriatric Assessment in Elderly Patients with End-Stage Kidney Disease
Blood Pressure Variability and Frailty in End-Stage Kidney Disease
Barriers to Implementing the Kidney Disease Outcomes Quality Initiative End-Stage Kidney Disease Life Plan Guideline
Validation of the kidney failure risk equation for end-stage kidney disease in Southeast Asia
Apolipoprotein A5 gene polymorphism (rs662799) and cardiovascular disease in end-stage kidney disease patients
Dysfunction of natural killer cells in end-stage kidney disease on hemodialysis
Epidemiology and aetiology of dialysis-treated end-stage kidney disease in Libya
LDLR gene polymorphism (rs688) affects susceptibility to cardiovascular disease in end-stage kidney disease patients